Prosecution Insights
Last updated: October 04, 2026

Hoffmann & Baron LLP

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

103 pending office actions • 77 clients • 99 examiners • 64 art units • 0 of 103 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Hoffmann and Baron, LLP manages 10348 career applications in Medical Devices & Mechanical Engineering. The firm currently has 1 pending office action. The resolved allowance rate pct is 80.2, representing the success rate for its resolved cases in this technology area. This volume of 10348 applications provides a significant baseline for evaluating the firm's long-term performance in mechanical patenting.

The average office actions per allowance is 3.32. This metric indicates the level of negotiation with examiners required to secure a patent grant. The firm's performance is grounded in its 10348 career applications and 80.2 resolved allowance rate pct. Practitioners can use the average of 3.32 office actions per allowance to estimate the resources needed for patent prosecution. The 1 pending office action suggests a very small current workload relative to the firm's historical volume.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=10348 apps, methodology: how we score firms)

80.2%
Allowance Rate
n=10348
+0.65σ
Allowance Rate (norm)
n=10348
3.3
OAs to Allowance
n=6395
-0.21σ
OAs to Allow (norm)
n=6395
1109 days
Time to Allowance
n=6395
+8.0pp
Interview Lift
n=10348
23.3%
RCE Rate
n=10348
1.2%
Appeal Rate
n=10348

Rejection Performance (% of received rejections ultimately overcome)

83.1%
§101 Overcome
n=604
79.0%
§102 Overcome
n=2552
79.7%
§103 Overcome
n=3954
81.9%
§112 Overcome
n=3488

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
17%
Top-3 CPC Share
n=10348
4
Practitioners
n=10348
2587.0
Apps / Practitioner
n=10348

Portfolio Summary

103
Total Pending OAs
62
Non-Final OAs
37
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 41 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

16
Overdue
2
Due this week
12
Due this month
6
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 41 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (16)Due ≤ 7 days (2)Due ≤ 30 days (12)Due ≤ 60 days (6)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

59
Hard (57%)
32
Medium (31%)
9
Easy (9%)
3
Unknown (3%)

Rejection Statute Mix

BucketCases
§101 + other7 (7%)
§103 only21 (20%)
§102 only3 (3%)
§112 only8 (8%)
Double-patenting only1 (1%)
Double-patenting + other8 (8%)
Multi-statute (no §101)52 (50%)
No statute on record3 (3%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

63
Life Sciences
61% of docket
1
Information Tech
1% of docket
1
Communications
1% of docket
3
Semiconductors
3% of docket
16
Mechanical / Eng
16% of docket
19
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,030 h
Manual time on pending OAs
206 h
Time saved (low, 20%)
360 h
Time saved (mid, 35%)
9.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOBSON, STEPHEN 2 65.4% +20.3%
STOICA, ELLY GERALD 2 66.9% +22.5%
GOLDBERG, JEANINE ANNE 2 45.8% +40.8%
BRISTOL, LYNN ANNE 2 63.4% +39.8%
MELCHIOR, JAMES RYLAND 1 63.0% +38.5%
REYES, REGINALD R 1 41.0% +31.9%
HODGE, LINDA J 1 87.5% +27.3%
JACKSON, MONIQUE R 1 34.9% +44.1%
STEVENS, ALLAN D 1 41.5% +50.3%
TRUONG, KATELYN T 1 57.0% +37.6%

Hard Cases (59)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18378432 Anorectal Rectal Junction Device RABAGLIA, BRIDGET ELIZABETH 88d overdue
17502238 Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof BRISTOL, LYNN ANNE 66d overdue
18808671 System for Mounting Photovoltaic Modules for an Overhead Structure CANNON, RYAN SMITH 18d overdue
18005813 T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof QIAN, CELINE X 18d overdue
17691107 DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES KIM, DANIELLE A 5d overdue
18284348 SYSTEM HAVING A GUIDE RAIL AND A CARRYING DEVICE DO, NHAT CHIEU Q 5d
18268118 USE OF SYNTHETIC PEPTIDE FOR THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNITY GOTFREDSON, GAREN 12d
18024002 CATALYTIC REACTOR WITH IMPROVED PROPERTIES LEUNG, JENNIFER A 12d

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17502238 Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof BRISTOL, LYNN ANNE 66d overdue
17928806 INORGANIC NANOPARTICLE-BASED VACCINE COMPOSITIONS FOR CANCER TREATMENT STOICA, ELLY GERALD 18d overdue
17994787 CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS THEREOF BRISTOL, LYNN ANNE 70d
19195720 ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents MELCHIOR, JAMES RYLAND —
19191089 SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES REYES, REGINALD R —
19111233 TRANSFER DEVICE FOR TRANSFERRING AN ARRAY OF DOSES OF MEDICINES HODGE, LINDA J —
19105886 THERMOCHROMIC MATERIALS WITH NANOPARTICLES JACKSON, MONIQUE R —
19100974 SNAP CAP STEVENS, ALLAN D —

Client Portfolio (77 clients)

Client (Assignee)Pending OAs
Leonhard Kurz 5
iCell Gene Therapeutics LLC 4
COÖPERATIE KONINKLIJKE AVEBE U.A. 4
Weener Plastics Group B.V. 3
Furanix Technologies 3
Cue Biopharma 3
Avantor 3
THE ROCKEFELLER UNIVERSITY 3
Aquestive Therapeutics 2
Mura Technology 2
La San Marco S.p.A. 2
Spig S.p.A. 2
PTC Therapeutics 2
CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA 2
Crosslink Therapeutics 1
Global Factories Total Engineering And Manufacturing B.V. 1
Chemelot Scientific Participations B.V. 1
R. Andringa Holding B.V. 1
Rearden Analytics 1
Korea Securities Lending Co., Ltd. 1
Mana Health Technologies GmbH 1
Enpulsion GmbH 1
Graphic Innovators, LLC 1
Daca Design LLC 1
SHIMIZU CORPORATION 1
OVD Kinegram AG 1
Jiangsu Hecheng Display Technology Co., Ltd. 1
Klasmann-Deilmann GmbH 1
SUNY 1
CATALENT PHARMA SOLUTIONS, LLC 1
Toyo Cushion Lanka (PVT) LTD 1
Daewoo Engineering & Construction Co., Ltd. 1
Lumos Solar 1
Beektech Industries B.V. 1
Applied DNA Sciences 1
Beihang University 1
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY 1
Yantai Hengchi Trailer Co., Ltd. 1
CHONGQING UNIVERSITY 1
Shanghai Academy Of Agricultural Sciences 1
Biomedit, LLC 1
Wps Horti Systems B.V. 1
DLR 1
Jiansheng Medical Technology Co., Ltd. 1
Sgs Ventures Inc. 1
AB Mauri (Uk) Ltd. 1
TOKAI CARBON CO., LTD. 1
MIT 1
Mercedes-Benz Group Ag. 1
Shaanxi University of Chinese Medicine 1
GI Reviewers, LLC 1
Shenzhen Blood Center (Shenzhen Institute Of Transfusion Medicine) 1
Tcs Patent B.V. 1
FESTOOL GMBH 1
NEW YORK UNIVERSITY 1
UNIVERSITÉ DE LIÈGE 1
PaperFoam Holding B.V. 1
Beijing Univ Civil Engn & Architecture 1
Government of Canada 1
Adulsa Therapeutics Corp. 1
CatIP B.V. 1
University of Tartu 1
Fondation Imagine 1
RWTH Aachen 1
Universidad de la Habana 1
THE TRUSTEES OF PRINCETON UNIVERSITY 1
Atex Technologies 1
Cooperatie Koninklijke Avebe U.A. 1
Hinterkopf 1
Supportive Therapeutics AG 1
House Foods 1
Toyo Seikan 1
Centro De Immunología Molecular 1
Biomiris Capital Group B.V. 1
UNIVERSITY HEALTH NETWORK 1
Katholieke Universiteit Leuven 1
Nederlandse Organisatie Voor Toegepast-natuurwetenschappelijk Onderzoek Tno 1

Top Art Units

Art UnitApps
16474
16833
16283
16442
17872
37362
16262
36432
16552
17922

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19195720 ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents Crosslink Therapeutics Inc. MELCHIOR, JAMES RYLAND 1644 §112DP Final Rejection — Pending Apr 30, 2025
19191089 SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES Aquestive Therapeutics, Inc. REYES, REGINALD R DP Non-Final OA — Pending Apr 28, 2025
19111233 TRANSFER DEVICE FOR TRANSFERRING AN ARRAY OF DOSES OF MEDICINES Global Factories Total Engineering And Manufacturing B.V. HODGE, LINDA J §102§103 Non-Final OA — Pending Mar 12, 2025
19105886 THERMOCHROMIC MATERIALS WITH NANOPARTICLES Chemelot Scientific Participations B.V. JACKSON, MONIQUE R 1787 §102§103§112 Non-Final OA — Pending Feb 24, 2025
19100974 SNAP CAP Weener Plastics Group B.V. STEVENS, ALLAN D 3736 §103§112 Non-Final OA — Pending Feb 04, 2025
18996380 A CUBICLE AND A STABLE R. Andringa Holding B.V. TRUONG, KATELYN T 3647 §102§103§112 Non-Final OA — Pending Jan 17, 2025
19027751 NETWORK-ENABLED GLOBAL POSITIONING SATELLITE-BASED DEVICE FOR OBTAINING PATIENT VERIFICATION Rearden Analytics NG, JONATHAN K 3619 §101§103Other Non-Final OA — Pending Jan 17, 2025
18724493 Method, System, and Non-Transitory Computer-Readable Recording Medium for Supporting Asset Transaction Korea Securities Lending Co., Ltd. POE, KEVIN T 3692 §101§103§112 Non-Final OA 23d Pending Dec 16, 2024
18975116 DECORATIVE FOIL, METHOD FOR PRODUCING A DECORATIVE FOIL AND METHOD FOR DECORATING A TARGET SUBSTRATE Leonhard Kurz Stiftung & Co. Kg KOCH, GEORGE R §102§103§112 Non-Final OA — Pending Dec 10, 2024
18871556 PRODUCING 2,5-FURANDICARBOXYLIC ACID FROM MIXED FEED Furanix Technologies B.V. HAVLIN, ROBERT H 1626 §103§112DP Non-Final OA — Pending Dec 04, 2024
18868889 DISPENSING CLOSURE WITH TAMPER-EVIDENT PUSH-BUTTON Weener Plastics Group B.V. SMALLEY, JAMES N 3733 §102§103 Non-Final OA — Pending Nov 25, 2024
18948847 TRANSFER FILM, COMPONENT, AND METHOD FOR THE PRODUCTION THEREOF Leonhard Kurz Stiftung & Co. Kg LIANG, SHIBIN §103§112 Non-Final OA — Pending Nov 15, 2024
18865801 RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION Mana Health Technologies GmbH PALENIK, JEFFREY T §103 Non-Final OA — Pending Nov 14, 2024
18862987 ION SOURCE Enpulsion GmbH VANORE, DAVID A 2881 §102 Non-Final OA — Pending Nov 05, 2024
18931317 PROCESS FOR FORMING IMPROVED PROTECTIVE ECO-FRIENDLY POUCH AND PACKAGING AND PRODUCTS MADE THEREFROM Graphic Innovators, LLC HELVEY, PETER N. 3736 §102§103 Non-Final OA — Pending Oct 30, 2024
18930407 SECUREMENT APPARATUS FOR A PORTABLE ELECTRONIC DEVICE Daca Design LLC WAGGENSPACK, ADAM J 3734 §103§112Other Non-Final OA — Pending Oct 29, 2024
18858989 AIR CONDITIONING SYSTEM AND AIR CONDITIONING METHOD Shimizu Corporation BANKS, KEONA LAUREN 3763 §103 Final Rejection — Pending Oct 22, 2024
18858811 LAMINATE AND METHOD FOR PRODUCING A LAMINATE Ovd Kinegram AG NORDMEYER, PATRICIA L 1788 §103 Final Rejection 33d Pending Oct 22, 2024
18857539 SINGLE-SIDE PEEP-PROOF LIQUID-CRYSTAL DISPLAY DEVICE Jiangsu Hecheng Display Technology Co., Ltd. CHIEN, LUCY P 2871 §102§103 Non-Final OA — Pending Oct 17, 2024
18854771 PLANT PLUG, MANUFACTURING METHOD AND USE THEREOF Klasmann-Deilmann GmbH ALMEIDA BONNIN, ANGELICA ALEJANDRA 3643 §103§112 Final Rejection — Pending Oct 07, 2024
18854537 HYDROTHERMAL TREATMENT OF MATERIALS Mura Technology Limited CEPLUCH, ALYSSA L §102§103§112 Non-Final OA — Pending Oct 06, 2024
18891727 Method for Nitrogen Removal and Nitrogen Salts Recovery Using Carboxylated Cellulose Extracted by Nitro-oxidation The Research Foundation for the State University of New York GURTOWSKI, RICHARD C §103 Non-Final OA — Pending Sep 20, 2024
18849392 LIQUID FORMULATIONS OF IVERMECTIN COMPOSITIONS AND USE IN GELATIN DOSAGE FORMS Catalent Pharma Solutions, LLC CHI, AMANDA LYNN §103§112 Non-Final OA — Pending Sep 20, 2024
18826507 WATERPROOF BIODEGRADABLE COIR POT WITH NATURAL SPECIAL WATERPROOF COATING Toyo Cushion Lanka (PVT) LTD BYUN, HAE RIE JESSICA 3643 §103 Final Rejection 87d overdue Pending Sep 06, 2024
18844132 MARINE STRUCTURE AND METHOD Daewoo Engineering & Construction Co., Ltd. VENNE, DANIEL V §102§103 Non-Final OA — Pending Sep 05, 2024
18808671 System for Mounting Photovoltaic Modules for an Overhead Structure Lumos Solar, Inc. CANNON, RYAN SMITH 1726 §102§103 Final Rejection 18d overdue Pending Aug 19, 2024
18837631 HEIGHT ADJUSTABLE VENTILATION SYSTEM Beektech Industries B.V. DALLO, JOSEPH J §102§103§112 Non-Final OA — Pending Aug 12, 2024
18836880 APPARATUS AND METHOD FOR GRINDING SEEDS La San Marco S.p.A. DICKSTEIN, WILLIAM DOUGLAS §102§103§112 Non-Final OA — Pending Aug 08, 2024
18727441 RETICULAR PANEL FOR A COOLING TOWER Spig S.p.A. HOBSON, STEPHEN §102§103§112 Non-Final OA — Pending Jul 09, 2024
18727446 THERMAL EXCHANGE PACK FOR A COOLING TOWER Spig S.p.A. HOBSON, STEPHEN §103§112 Non-Final OA — Pending Jul 09, 2024
18740403 Methods and vectors for in vitro transcription of mRNA with reduced levels of dsRNA Applied DNA Sciences, Inc. ZAHORIK, AMANDA MARY §103§112 Non-Final OA — Pending Jun 11, 2024
18735752 EFFICIENT CHATTER CUTTING METHOD FOR DIFFICULT-TO-MACHINE MATERIALS BEIHANG UNIVERSITY SNYDER, ALAN W §102§103 Final Rejection — Pending Jun 06, 2024
18716599 MULTI-APPLICATION MODULE, MULTI-APPLICATION DEVICE, AND WORKING METHOD FOR A MULTI-APPLICATION DEVICE Leonhard Kurz Stiftung & Co. Kg THOMPSON, LESLIE J. 2853 §103§112 Non-Final OA — Pending Jun 05, 2024
18714631 NOVEL NON-FLUORINATED QUINOLONE COMPOUND AND USE THEREOF Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory OTTON, ALICIA L §112 Non-Final OA — Pending May 30, 2024
18640622 RELAY TYPE DUMP TRUCK Yantai Hengchi Trailer Co., Ltd. SCHUSTER, ALMA DONGFENG 3612 §102§112 Non-Final OA — Pending Apr 19, 2024
18700394 METHOD FOR DETECTING INSULATOR FAULT OF TRANSMISSION LINE BASED ON USRNet AND IMPROVED MobileNet-SSD ALGORITHM Chongqing University VAZ, JANICE EZVI 2667 §103 Final Rejection 47d Pending Apr 11, 2024
18629619 CONSTRUCTION METHOD OF BACTERIAL CELLULOSE (BC)-ENRICHED PLANT USING MULTI-GENE TANDEM AND USE THEREOF Shanghai Academy Of Agricultural Sciences DELEO, VICTORIA LYNN 1662 §103§112 Non-Final OA — Pending Apr 08, 2024
18694118 Methods of Inhibiting Diseases Caused by Respiratory Viruses Biomedit, LLC ZEMAN, ROBERT A 1645 §103§112Other Non-Final OA — Pending Mar 21, 2024
18437270 NURSERY ASSEMBLY Wps Horti Systems B.V. HAGEMAN, MARK C 3652 §102§103§112 Non-Final OA — Pending Feb 09, 2024
18425696 COCKPIT WITH VIRTUAL CONTROL ELEMENTS DEUTSCHES ZENTRUM FÜR LUFT- UND RAUMFAHRT E.V. BIANCAMANO, ALYSSA N 3715 §103§112 Final Rejection — Pending Jan 29, 2024
18425001 SELF-CLOSING DISPENSING VALVE MADE OF A PLASTOMER OR A THERMOPLASTIC ELASTOMER Weener Plastics Group B.V. ZADEH, BOB 3754 §102§103 Non-Final OA 14d Pending Jan 29, 2024
18425986 Reproducible Double Unique Dual Indexing Library Construction Method for Next Generation Sequencing of microRNA Isoform and Use Thereof Jiansheng Medical Technology Co., Ltd. HOPPE, EMMA RUTH 1683 §101§102§112 Non-Final OA — Pending Jan 29, 2024
18411101 COMPOUND CHIMERIC ANTIGEN RECEPTOR (CCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF ICELL GENE THERAPEUTICS INC. REDDIG, PETER J 1646 §102DP Non-Final OA — Pending Jan 12, 2024
18410519 SYSTEM AND METHOD FOR MANAGING RELATIONSHIPS, ORGANIZATION, RETRIEVAL, AND SHARING OF DIFFERENT TYPES OF CONTENTS ACCESSIBLE BY A COMPUTING DEVICE Sgs Ventures Inc. OSMAN, RAMY M 2457 §103§112 Final Rejection — Pending Jan 11, 2024
18575677 PHYSIOLOGICALLY ACCEPTABLE YEAST COMPOSITIONS FOR USE IN THE TREATMENT OF A GASTRO-INTESTINAL DISORDER AB Mauri (Uk) Ltd. FIEBIG, RUSSELL G 1655 §103§112 Non-Final OA — Pending Dec 29, 2023
18575113 POLYCRYSTALLINE SIC FORMED BODY AND METHOD FOR PRODUCING THE SAME Tokai Carbon Co., Ltd. SONG, MATTHEW J 1714 §102§103 Final Rejection 14d Pending Dec 28, 2023
18530612 METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY Massachusetts Institute Of Technology WELLS, LAUREN QUINLAN 1622 §103 Non-Final OA 5d overdue Pending Dec 06, 2023
18564360 AMYLOPECTIN STARCH FOR BINDING OF MEAT PRODUCTS Coöperatie Koninklijke Avebe U.A. BEKKER, KELLY JO 1792 §103§112 Non-Final OA — Pending Nov 27, 2023
18255452 CHARGING SYSTEM, VOLTAGE CONVERTER UNIT, AND ACCUMULATOR UNIT Mercedes-Benz Group Ag. DIAO, M BAYE §102§103§112 Non-Final OA — Pending Oct 26, 2023
18287705 INSULATION MATERIAL, METHOD FOR PRODUCING AN INSULATION MATERIAL, AND METHOD FOR RECYCLING AN INSULATION MATERIAL Leonhard Kurz Stiftung & Co. Kg SHAH, SAMIR 1787 §103 Final Rejection — Pending Oct 20, 2023
18287739 Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof Cue Biopharma, Inc. AEDER, SEAN E 1654 §112DP Non-Final OA — Pending Oct 20, 2023
18287747 Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof Cue Biopharma, Inc. STOICA, ELLY GERALD 1647 §112DP Non-Final OA — Pending Oct 20, 2023
18380875 METHOD FOR EXTRACTING AND PURIFYING TOTAL FLAVONOIDS FROM CARTHAMUS TINCTORIUS L. LEAF (TFFCL), AND USE THEREOF Shaanxi University Of Chinese Medicine BOECKELMAN, JACOB A 1655 §103 Non-Final OA 1d overdue Pending Oct 17, 2023
18286591 COFFEE PERCOLATOR AND METHOD OF DELIVERING COFFEE La San Marco S.p.A. KRASNOW, NICHOLAS R §112 Non-Final OA — Pending Oct 12, 2023
18378432 Anorectal Rectal Junction Device Gi Reviewers, LLC RABAGLIA, BRIDGET ELIZABETH 3771 §102§103 Final Rejection 88d overdue Pending Oct 10, 2023
18285918 PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS Avantor Performance Materials, LLC TRUONG, QUANGLONG N 1615 — Non-Final OA 117d overdue Pending Oct 06, 2023
18376678 METHOD FOR DETECTING DRUG ANTIBODY IN SPECIMEN Shenzhen Blood Center (Shenzhen Institute Of Transfusion Medicine) JOHANSEN, PETER N. 1644 §112 Non-Final OA 77d Pending Oct 04, 2023
18553653 LABORATORY SYSTEM FOR SAMPLING REACTOR CONTENTS Tcs Patent B.V. BORTOLI, JONATHAN 1797 §102§103 Non-Final OA — Pending Oct 02, 2023
18284348 SYSTEM HAVING A GUIDE RAIL AND A CARRYING DEVICE Festool GmbH DO, NHAT CHIEU Q 3724 §102§103 Final Rejection 5d Pending Sep 27, 2023
18370695 MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME New York University FISCHER, JOSEPH 1658 §112Other Non-Final OA — Pending Sep 20, 2023
18240579 Self-blowing isocyanate-free polyurethane foams Université De Liège RIETH, STEPHEN EDWARD 1759 §103§112 Final Rejection — Pending Aug 31, 2023
18279275 PATATIN-EMULSIFIED BINDER Coöperatie Koninklijke Avebe U.A. MCCLAIN, TYNESHA L. 1793 §103§112 Non-Final OA — Pending Aug 29, 2023
18278134 MOLD AND METHOD FOR MOLD FORMING PRODUCTS Paperfoam Holding B.V. KIM, YUNJU 1742 §102§103 Final Rejection — Pending Aug 21, 2023
18264183 METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 Ptc Therapeutics, Inc. MOU, LIYUAN 1628 §103§112DP Final Rejection 29d Pending Aug 03, 2023
18216837 IMMOBILIZED CRUDE ENZYME FOR DEGRADING COMPLEX POLYCYCLIC AROMATIC HYDROCARBONs (PAHs) IN SOIL AND PREPARATION METHOD THEREOF Beijing Univ Civil Engn & Architecture STEADMAN, DAVID J 1656 §103§112 Non-Final OA 48d Pending Jun 30, 2023
18268118 USE OF SYNTHETIC PEPTIDE FOR THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNITY Centro De Ingeniería Genética Y Biotecnología GOTFREDSON, GAREN 1619 §102§103§112 Non-Final OA 12d Pending Jun 16, 2023
18037388 POLYESTER COMPOSITION WITH IMPROVED IMPACT PROPERTIES Furanix Technologies B.V. BROOKS, KREGG T 1764 §103§112 Final Rejection 29d Pending May 17, 2023
18033854 AN AGGLOMERATION-BASED OIL-WATER SEPARATION PROCESS His Majesty The King In Right Of Canada AS Represented By The Minister Of Natural Resources STEIN, MICHELLE 1771 §103 Non-Final OA 37d overdue Pending Apr 26, 2023
18031517 MEMBRANE RUPTURE COMPOSITIONS AND METHODS OF MAKING AND USING SAME Avantor Performance Materials, LLC BATES, KEENAN ALEXANDER 1631 §102§103§112 Non-Final OA — Pending Apr 12, 2023
18026229 METHODS OF INHIBITING DISEASES CAUSED BY RESPIRATORY VIRUSES Adulsa Therapeutics Corp. BARSKY, JARED 1628 §103 Non-Final OA 83d Pending Mar 14, 2023
18024002 CATALYTIC REACTOR WITH IMPROVED PROPERTIES Catip B.V. LEUNG, JENNIFER A 1774 §103§112 Non-Final OA 12d Pending Feb 28, 2023
18022000 METHOD OF PROGNOSING PREECLAMPSIA UNIVERSITY OF TARTU KAPUSHOC, STEPHEN THOMAS 1683 §101§112 Final Rejection — Pending Feb 17, 2023
18017900 PPREPARING POLYESTER COMPRISING 2,5-FURANDICARBOXYLATE UNITS WITH GERMANIUM CATALYST Furanix Technologies B.V. FANG, SHANE 1766 §102 Non-Final OA — Pending Jan 25, 2023
18017249 Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 Fondation Imagine COUNTS, GARY W 1678 §101§103§112 Non-Final OA — Pending Jan 20, 2023
18005813 T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof Cue Biopharma, Inc. QIAN, CELINE X 1637 §102§103§112Other Final Rejection 18d overdue Pending Jan 17, 2023
18014274 POLYMERIC MICELLES COMPRISING GLUCURONIDE-PRODRUGS Rheinisch-Westfälische Technische Hochschule Aachen PHAN, DOAN THI-THUC 1613 §103 Non-Final OA 4d overdue Pending Jan 03, 2023
17928806 INORGANIC NANOPARTICLE-BASED VACCINE COMPOSITIONS FOR CANCER TREATMENT Universidad de la Habana STOICA, ELLY GERALD 1647 §103 Non-Final OA 18d overdue Pending Nov 30, 2022
17928513 MARKERS AND CELLULAR ANTECEDENTS OF RHEUMATOID ARTHRITIS FLARES The Trustees of Princeton University GOLDBERG, JEANINE ANNE 1682 §101§102§112DPOther Non-Final OA — Pending Nov 29, 2022
18070855 ULTRA-THIN FABRIC, DEVICES, AND METHODS Atex Technologies, Inc. KOSACK, JOSEPH R 3991 Other Final Rejection 26d Pending Nov 29, 2022
17928424 METHOD AND SYSTEM FOR RNA ISOLATION FROM SELF-COLLECTED AND SMALL VOLUME SAMPLES The Rockefeller University GUSSOW, ANNE 1683 §102§103§112 Final Rejection — Pending Nov 29, 2022
17994787 CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS THEREOF ICELL GENE THERAPEUTICS INC. BRISTOL, LYNN ANNE 1643 §112Other Non-Final OA 70d Pending Nov 28, 2022
17994883 CHIMERIC ANTIGEN RECEPTORS (CARs), TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOF ICELL GENE THERAPEUTICS INC. WESTON, ALYSSA G 1633 Other Final Rejection 40d Pending Nov 28, 2022
17994090 MARKERS AND CELLULAR ANTECEDENTS OF RHEUMATOID ARTHRITIS FLARES The Rockefeller University GOLDBERG, JEANINE ANNE 1682 §101§102§112DPOther Non-Final OA — Pending Nov 25, 2022
17927414 FIBER SUPPLEMENTED ACIDIFIED DAIRY PRODUCTS AND METHODS FOR PROVIDING THE SAME Cooperatie Koninklijke Avebe U.A. LIU, DEBORAH YANG-HAO 1791 §103 Non-Final OA — Pending Nov 23, 2022
17918299 PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROME Centro De Ingeniería Genética Y Biotecnología BUNNER, BRIDGET E 1647 §103§112Other Final Rejection 16d Pending Oct 11, 2022
17953461 DIGITAL PRINTING MACHINE AND METHOD FOR PRODUCING AND PRINTING A WORKPIECE Hinterkopf GmbH LAN, YAN 1782 §103 Final Rejection 4d overdue Pending Sep 27, 2022
17946789 Rotomeric Isomers of 4-Alkyl-5-Heteroaryl-3H-1,2-Dithiole-3-Thiones Supportive Therapeutics AG SZNAIDMAN, MARCOS L 1628 DPOther Final Rejection 79d Pending Sep 16, 2022
17911322 POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USING Avantor Performance Materials, LLC BEANE, RANDALL L 1654 §112 Final Rejection 19d Pending Sep 13, 2022
17802643 METHOD AND DEVICE FOR DECORATING AN INJECTION-MOLDED PART, AND INJECTION MOLDED-PART Leonhard Kurz Stifting & Co. Kg LEE, EDMUND H 1744 §103 Final Rejection 44d overdue Pending Aug 26, 2022
17800771 MIXED SPICE AND MASKING COMPOSITION THAT CONTAINS SAME House Foods Corporation LI, CHANGQING 1791 §103 Final Rejection 23d overdue Pending Aug 18, 2022
17794724 PHASE SEPARATION SENSORS AND USES THEREOF The Rockefeller University DEBERRY, REGINA M 1647 §112 Final Rejection — Pending Jul 22, 2022
17792801 POROUS SILICA, DEODORANT AGENT, AND METHOD FOR PRODUCING DEODORANT AGENT Toyo Seikan Group Holdings, Ltd. LACLAIR, LOGAN EDWARD 1736 §102§103 Final Rejection 36d Pending Jul 14, 2022
17786094 STABLE HIGH-CONCENTRATION FORMULATION OF NIMOTUZUMAB ANTIBODY Centro De Immunología Molecular KIM, YUNSOO 1641 §102 Final Rejection 48d Pending Jun 16, 2022
17783941 COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA Ptc Therapeutics, Inc. ANDERSON, REBECCA L 1626 §103DPOther Final Rejection 14d Pending Jun 09, 2022
17781480 METHODS FOR IDENTIFYING MICROBES IN A CLINICAL AND NON-CLINICAL SETTING Biomiris Capital Group B.V. HAMMELL, NEIL P 1681 §112 Final Rejection 133d overdue Pending Jun 01, 2022
17768912 PLASTICISER FREE BARRIER COMPOSITION Coöperatie Koninklijke Avebe U.A. HON, SOW FUN 1782 §103 Non-Final OA — Pending Apr 14, 2022
17714543 METHOD AND APPARATUS FOR PRODUCING BIOFUEL Mura Technology Limited PO, MING CHEUNG 1771 §103 Non-Final OA — Pending Apr 06, 2022
17691107 DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES Aquestive Therapeutics, Inc. KIM, DANIELLE A 1613 §103§112 Non-Final OA 5d overdue Pending Mar 09, 2022
17620103 FUROSEMIDE ANALOGUES AND COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ALZHEIMER'S DISEASE UNIVERSITY HEALTH NETWORK CHENG, KAREN 1623 §102§103 Non-Final OA 23d Pending Dec 16, 2021
17502238 Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof ICELL GENE THERAPEUTICS INC. BRISTOL, LYNN ANNE 1643 §102§112Other Final Rejection 66d overdue Pending Oct 15, 2021
17293982 COPPER, GOLD, OR SILVER POWDER FOR POWDER BED ADDITIVE MANUFACTURING AND METHOD OF MANUFACTURING SUCH POWDER Katholieke Universiteit Leuven SMITH, CATHERINE P 1735 §103 Final Rejection 61d Pending May 14, 2021
17282236 MILK SUBSTITUTE Coöperatie Koninklijke Avebe U.A. KIM, BRYAN 1792 §103§112 Non-Final OA — Pending Apr 01, 2021
16968050 INTEGRATED ELECTROCHEMICAL CAPTURE AND CONVERSION OF CARBON DIOXIDE Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno PARENT, ALEXANDER RENE 1795 §103 Final Rejection 7d Pending Aug 06, 2020

Managing Hoffmann & Baron LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month